Cytomedix, Inc. (OTC:CMXI) published a 10-Q on May 16. The volume that day was huge, but the price decreased slightly. On May 17 it went up sharply, only to drop back the next day.
Yesterday, CMXI closed at $0.39. This was a 0.26% drop on 341 thousand shares. Volume has been consistently higher than the average since the 10-Q.[BANNER]
The company also held an earnings call on May 17. Here are some of the numbers, which seem to have caused the heightened interest in CMXI:
- $1 million in cash
- $3.8 million total current assets
- $4.2 million total current liabilities
- $1.3 million sales
- $1.4 million net loss
While CMXI still operates at a loss, it has strengthened its balance sheet significantly through the retirement of part of its debt. If the sales grow and the company manages to decrease its expenses, it could move a lot higher than the current prices.
On the other hand, the company has issued a new promissory note and has sold some common shares, which has had a dilutive effect on CMXI stock. For now, the company’s future is still uncertain, but the recent developments could bring hope for shareholders.
